NARECHEM-ST Clinical Data/Follow-up

  • Second primary tumors in association with current disease are provided in collaboration with treating personnel
    • Clinical and follow-up outcome data, including relapses, bone marrow transplantation and survival of registered patients are provided by treating personnel and reviewed on an annual basis
      • Long-term follow-up of all registered patients (late effects, second malignancies, survival) is conducted and needs to be further systematized